Serrano, Daniel
Cella, David
Husereau, Don
King-Kallimanis, Bellinda
Mendoza, Tito
Salmonson, Tomas
Stone, Arthur
Zaleta, Alexandra
Dhanda, Devender
Moshyk, Andriy
Liu, Fei
Shields, Alan L.
Taylor, Fiona
Spite, Sasha
Shaw, James W.
Braverman, Julia
Funding for this research was provided by:
Bristol-Myers Squibb
Article History
Accepted: 11 December 2023
First Online: 24 January 2024
Declarations
:
: A.Z.: Cancer Support Community, Research and Training Institute (employment); institutional research funding from Astellas, Boston Scientific Foundation, Gilead Sciences, Novartis, Pfizer Inc., and Seagen Inc.; Bristol Myers Squibb (BMS) (consultancy). A.S.: Adelphi Values (consultancy) and the Gallup Organization (senior scientist). B.K.: LUNGevity Foundation (employment), AstraZeneca (grants), G1 Therapeutics (grants), BMS (grants), Merck (grants), Blueprint Medicine (grants), Eli Lilly (grants and consultancy), Genentech (grants), Takeda (grants), Jazz Pharmaceuticals (grants), Novartis (grants), Jansen (grants), Health Outcome Solutions (consultancy), and Atheneum (consultancy). D.S.: The Psychometrics Team (employment), Pharmerit International (employment), Vedanta Research (consultancy), and BMS (consultancy). D.C.: FACITtrans, LLC, Functional Assessment of Chronic Illness Therapy (FACIT.org), PROMIS Health Organization, AbbVie, Inc. (consultancy), Alexion Pharmaceuticals, Inc. (consultancy), Amgen, Inc. (consultancy), Astellas Pharma Global Development, Inc. (Astellas Pharma US, Inc.) (consultancy), Black Diamond Therapeutics (consultancy), Boehringer Ingelheim Pharmaceuticals, Inc. (Boehringer Ingelheim GmbH) (consultancy), BMS (consultancy), Celcuity, Inc. (consultancy), Corcept Therapeutics (consultancy), Daiichi Sankyo Company, Limited (consultancy), Disc Medicine (consultancy), Dompe (consultancy), Eisai, Inc. (consultancy), Eli Lilly and Company (consultancy), Evidera (consultancy), Genzyme Corporation (consultancy), Georgetown University (consultancy), GlaxoSmithKline (consultancy), H. Lee Moffitt Cancer Center and Research Institute (consultancy), Inmagene LLC (consultancy), Kiniksa Pharmaceuticals (consultancy), Leidos (consultancy), MD Anderson (consultancy), MEI Pharma (consultancy), Merck and Co., Inc. (consultancy), National Cancer Institute (consultancy), Novartis (consultancy), RAND Corporation (consultancy), Rafael Pharmaceuticals (consultancy), Takeda Pharmaceuticals North America, Inc. and Novo Nordisk A/S (consultancy), University of Arkansas for Medical Sciences (consultancy), UpToDate, Inc. (consultancy), and Yale School of Medicine (consultancy). D.H.: University of Ottawa (faculty), ISPOR (consultancy), and BMS (consultancy). T.M.: University of Texas MD Anderson Cancer center (faculty), Amgen, Inc (consultancy), and BMS (consultancy). T.S.: Consilium Salmonson and Hemmings (employment) and BMS (consultancy). J.B.: BMS (employment and stock ownership). A.M.: BMS (employment and stock ownership). D.D.: BMS (employment and stock ownership). F.L.: BMS (employment and stock ownership). J.S.: BMS (employment and stock ownership). A.S.: Adelphi Values (employment). F.T.: Adelphi Values (employment). S.S.: Adelphi Values (employment).